CXCL1 and ovarian cancer: As the augmented GROα in the CM of Yap1-depleted stromal cells significantly exerted in vitro efficacy in promoting the progression and aggression of ovarian cancer cells, it is of interest to determine whether GROα also stimulates in vivo tumor dissemination in a syngeneic mouse model of ovarian cancer.